包装 | 价格(元) |
10mg | 电议 |
50mg | 电议 |
Cell lines | HCT-116 colon cancer cells (expressing GFP-UBXN2A) |
Preparation method | The solubility of this compound in DMSO is >10mM. General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months. |
Reacting condition | 20 and 40 μM, 24 hours |
Applications | Veratridine is the main UBXN2A enhancer, increased UBXN2A protein levels in a dose-dependent manner. |
Animal models | C57Bl/6N mice( HCT-116 cells expressing GFP-UBXN2A were injected into 6 to 8 week old nude female mice) |
Dosage form | Intraperitoneal injection (IP), 0.125 mg/kg for 28 days |
Application | Veratridine (VTD) was sufficient to induce UBXN2A protein levels, resulting in colon cancer cell death in UBXN2A- and mot-2-dependent manners. |
Other notes | Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
产品描述 | Voltage-gated Na+channel opener; increases intracellular Ca2+with no effect on the Na+/Ca2+exchanger. Steroid-derived alkaloid neurotoxin. Increases membrane Na+permeability and depolarizes excitable tissues. Reference: |